Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences ROA 2011-2025 | USNA

Current and historical return on assets (ROA) values for USANA Health Sciences (USNA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
USANA Health Sciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-09-30 $0.02B $0.73B 2.16%
2025-06-30 $0.03B $0.74B 4.69%
2025-03-31 $0.03B $0.75B 4.86%
2024-12-31 $0.04B $0.75B 6.27%
2024-09-30 $0.06B $0.67B 8.58%
2024-06-30 $0.06B $0.63B 8.82%
2024-03-31 $0.06B $0.63B 10.06%
2023-12-31 $0.06B $0.63B 10.32%
2023-09-30 $0.06B $0.60B 9.80%
2023-06-30 $0.06B $0.60B 10.67%
2023-03-31 $0.07B $0.61B 11.22%
2022-12-31 $0.07B $0.60B 12.08%
2022-09-30 $0.08B $0.56B 13.42%
2022-06-30 $0.09B $0.56B 15.38%
2022-03-31 $0.11B $0.57B 18.44%
2021-12-31 $0.12B $0.58B 19.89%
2021-09-30 $0.14B $0.58B 22.70%
2021-06-30 $0.14B $0.59B 23.38%
2021-03-31 $0.13B $0.59B 22.45%
2020-12-31 $0.13B $0.64B 22.86%
2020-09-30 $0.12B $0.58B 22.49%
2020-06-30 $0.11B $0.51B 22.38%
2020-03-31 $0.10B $0.47B 20.75%
2019-12-31 $0.10B $0.52B 19.38%
2019-09-30 $0.10B $0.46B 19.23%
2019-06-30 $0.11B $0.53B 19.31%
2019-03-31 $0.12B $0.55B 21.23%
2018-12-31 $0.13B $0.55B 22.16%
2018-09-30 $0.09B $0.60B 15.72%
2018-06-30 $0.08B $0.58B 15.20%
2018-03-31 $0.07B $0.55B 13.46%
2017-12-31 $0.06B $0.52B 12.36%
2017-09-30 $0.09B $0.49B 18.38%
2017-06-30 $0.10B $0.53B 20.08%
2017-03-31 $0.10B $0.47B 22.04%
2016-12-31 $0.10B $0.47B 22.77%
2016-09-30 $0.10B $0.44B 23.87%
2016-06-30 $0.10B $0.41B 23.00%
2016-03-31 $0.10B $0.43B 22.78%
2015-12-31 $0.10B $0.42B 23.09%
2015-09-30 $0.09B $0.44B 23.38%
2015-06-30 $0.09B $0.41B 23.42%
2015-03-31 $0.08B $0.38B 22.60%
2014-12-31 $0.08B $0.35B 21.81%
2014-09-30 $0.08B $0.32B 21.26%
2014-06-30 $0.07B $0.36B 20.49%
2014-03-31 $0.08B $0.37B 22.79%
2013-12-31 $0.08B $0.37B 24.94%
2013-09-30 $0.08B $0.33B 26.42%
2013-06-30 $0.08B $0.30B 27.77%
2013-03-31 $0.07B $0.27B 26.14%
2012-12-31 $0.07B $0.27B 24.74%
2012-09-30 $0.06B $0.27B 23.37%
2012-06-30 $0.06B $0.26B 22.42%
2012-03-31 $0.05B $0.27B 22.46%
2011-12-31 $0.05B $0.24B 22.57%
2011-09-30 $0.05B $0.23B 22.82%
2011-06-30 $0.05B $0.21B 24.04%
2011-03-31 $0.05B $0.21B 24.42%
2010-12-31 $0.05B $0.22B 26.47%
2010-09-30 $0.04B $0.20B 29.28%
2010-06-30 $0.04B $0.14B 30.00%
2010-03-31 $0.04B $0.13B 29.84%
2009-12-31 $0.03B $0.12B 28.10%
2009-09-30 $0.03B $0.12B 23.14%
2009-06-30 $0.03B $0.12B 23.14%
2009-03-31 $0.03B $0.12B 24.17%
2008-12-31 $0.03B $0.12B 24.27%
2008-09-30 $0.04B $0.12B 31.03%
2008-06-30 $0.04B $0.12B 35.06%
2008-03-31 $0.04B $0.12B 37.65%
2007-12-31 $0.05B $0.11B 43.06%
2007-09-30 $0.04B $0.10B 43.03%
2007-06-30 $0.04B $0.10B 43.65%
2007-03-31 $0.04B $0.11B 45.65%
2006-12-31 $0.04B $0.10B 46.38%
2006-09-30 $0.04B $0.09B 50.16%
2006-06-30 $0.04B $0.07B 48.93%
2006-03-31 $0.04B $0.09B 47.20%
2005-12-31 $0.04B $0.07B 46.43%
2005-09-30 $0.04B $0.10B 45.51%
2005-06-30 $0.04B $0.08B 45.86%
2005-03-31 $0.03B $0.09B 44.44%
2004-12-31 $0.03B $0.07B 43.32%
2004-09-30 $0.03B $0.08B 41.48%
2004-06-30 $0.03B $0.07B 41.94%
2004-03-31 $0.02B $0.07B 39.83%
2003-12-31 $0.02B $0.07B 41.18%
2003-09-30 $0.02B $0.05B 38.20%
2003-06-30 $0.01B $0.05B 32.10%
2003-03-31 $0.01B $0.04B 29.33%
2002-12-31 $0.01B $0.04B 21.62%
2002-09-30 $0.01B $0.04B 16.67%
2002-06-30 $0.01B $0.04B 13.79%
2002-03-31 $0.00B $0.04B 8.16%
2001-12-31 $0.00B $0.04B 5.52%
2001-09-30 $0.00B $0.04B 5.52%
2001-06-30 $0.00B $0.04B 2.72%
2001-03-31 $0.00B $0.03B 2.70%
2000-12-31 $0.00B $0.04B 5.23%
2000-09-30 $0.00B $0.04B 7.74%
2000-06-30 $0.00B $0.04B 5.19%
2000-03-31 $0.00B $0.04B 10.32%
1999-12-31 $0.01B $0.04B 12.74%
1999-09-30 $0.01B $0.04B 15.00%
1999-06-30 $0.01B $0.04B 25.32%
1999-03-31 $0.01B $0.04B 26.32%
1998-12-31 $0.01B $0.04B 27.97%
1998-09-30 $0.01B $0.04B 27.91%
1998-06-30 $0.01B $0.03B 27.59%
1998-03-31 $0.01B $0.03B 31.07%
1997-12-31 $0.01B $0.03B 30.77%
1997-09-30 $0.01B $0.02B 27.91%
1997-06-30 $0.01B $0.02B 25.00%
1997-03-31 $0.00B $0.02B 21.62%
1996-12-31 $0.00B $0.02B 24.62%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.346B $0.855B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.154B 33.86
Zoetis (ZTS) United States $52.354B 18.74
Takeda Pharmaceutical (TAK) Japan $44.993B 9.18
BeOne Medicines - (ONC) Switzerland $44.644B 218.97
Daiichi Sankyo, - (DSNKY) Japan $41.960B 20.90
Sandoz Group AG (SDZNY) Switzerland $30.210B 0.00
United Therapeutics (UTHR) United States $20.319B 17.88
Merck (MKKGY) Germany $17.344B 10.69
Shionogi (SGIOY) Japan $14.581B 13.39
Neurocrine Biosciences (NBIX) United States $14.314B 34.34
Summit Therapeutics (SMMT) United States $13.071B 0.00
IPSEN (IPSEY) France $12.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.569B 0.00
Ionis Pharmaceuticals (IONS) United States $11.866B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.668B 0.00
Corcept Therapeutics (CORT) United States $7.902B 85.36
Stevanato Group S.p.A (STVN) Italy $6.514B 36.46
Grifols, S.A (GRFS) Spain $5.844B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.372B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.672B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.640B 17.28
Hypermarcas (HYPMY) Brazil $3.072B 21.09
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Dyne Therapeutics (DYN) United States $2.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.773B 8.85
Soleno Therapeutics (SLNO) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.533B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.248B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.042B 24.20
Guardian Pharmacy Services (GRDN) United States $1.794B 34.55
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Harrow (HROW) United States $1.492B 91.57
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.436B 0.00
Collegium Pharmaceutical (COLL) United States $1.433B 7.10
Oruka Therapeutics (ORKA) United States $1.367B 0.00
Enliven Therapeutics (ELVN) United States $1.291B 0.00
Nektar Therapeutics (NKTR) United States $1.212B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Relay Therapeutics (RLAY) United States $1.147B 0.00
Xencor (XNCR) United States $1.115B 0.00
Evotec AG (EVO) Germany $1.052B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Theravance Biopharma (TBPH) United States $0.914B 38.38
Savara (SVRA) United States $0.855B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.772B 6.89
Organogenesis (ORGO) United States $0.760B 0.00
KalVista Pharmaceuticals (KALV) United States $0.751B 0.00
ARS Pharmaceuticals (SPRY) United States $0.724B 0.00
Aquestive Therapeutics (AQST) United States $0.710B 0.00
Lexeo Therapeutics (LXEO) United States $0.692B 0.00
Esperion Therapeutics (ESPR) United States $0.674B 0.00
ProKidney (PROK) United States $0.662B 0.00
4D Molecular Therapeutics (FDMT) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.624B 0.00
Bioventus (BVS) United States $0.584B 11.97
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.508B 12.04
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Altimmune (ALT) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.423B 5.78
Galectin Therapeutics (GALT) United States $0.387B 0.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 21.39
Silence Therapeutics (SLN) United Kingdom $0.316B 0.00
Avalo Therapeutics (AVTX) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Larimar Therapeutics (LRMR) United States $0.292B 0.00
Pyxis Oncology (PYXS) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.265B 0.00
Achieve Life Sciences (ACHV) Canada $0.234B 0.00
OmniAb (OABI) United States $0.219B 0.00
Protara Therapeutics (TARA) United States $0.215B 0.00
AleAnna (ANNA) United States $0.211B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Relmada Therapeutics (RLMD) United States $0.132B 0.00
Unicycive Therapeutics (UNCY) United States $0.124B 0.00
Avita Medical (RCEL) United States $0.118B 0.00
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Prelude Therapeutics (PRLD) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.099B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
VAXART, INC (VXRT) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.75
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Acrivon Therapeutics (ACRV) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Fractyl Health (GUTS) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.070B 0.00
Plus Therapeutics (PSTV) United States $0.065B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Talphera (TLPH) United States $0.062B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Wellgistics Health (WGRX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
Liminatus Pharma (LIMN) United States $0.029B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.028B 23.75
Vyome Holdings (HIND) United States $0.028B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Inotiv (NOTV) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00